XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of cash flows [abstract]      
Cash flow from operations $ 18,762 $ 33,414 $ 18,894
Interest on loans and borrowings paid (785) (693) (755)
Cash paid on settlement of derivatives, net (83) (197) (34)
Payments related to Brumadinho event (1,093) (1,388) (516)
Payments related to de-characterization of dams (349) (338) (293)
Interest on participative shareholders' debentures paid (371) (418) (183)
Income taxes (including settlement program) (4,637) (4,385) (1,736)
Net cash generated by operating activities from continuing operations 11,444 25,995 15,377
Net cash generated (used) in operating activities from discontinued operations 41 (316) (1,055)
Net cash generated by operating activities 11,485 25,679 14,322
Cash flow from investing activities:      
Capital expenditures (5,446) (5,033) (4,227)
Additions to investments (42) (131)
Proceeds from the sale of investments, net 586 714 407
Dividends received from associates and joint ventures 219 190 173
Short-term investment 260 582 (194)
Other investments activities, net (202) (552) (568)
Net cash used in investing activities from continuing operations (4,583) (4,141) (4,540)
Net cash used in investing activities from discontinued operations (103) (2,469) (129)
Net cash used in investing activities (4,686) (6,610) (4,669)
Cash flow from financing activities:      
Loans and borrowings from third-parties 1,275 930 6,800
Payments of loans and borrowings from third-parties (2,300) (1,927) (6,064)
Payments of leasing (224) (215) (204)
Dividends and interest on capital paid to shareholders (6,603) (13,483) (3,350)
Dividends and interest on capital paid to noncontrolling interest (12) (30) (14)
Shares buyback program (6,036) (5,546)
Transactions with noncontrolling shareholders of PTVI 278
Transactions with noncontrolling shareholders of MBR (107)
Net cash used in financing activities from continuing operations (13,900) (20,271) (2,661)
Net cash used in financing activities from discontinued operations (11) (13) (15)
Net cash used in financing activities (13,911) (20,284) (2,676)
Increase (reduction) in cash and cash equivalents (7,112) (1,215) 6,977
Cash and cash equivalents in the beginning of the year 11,721 13,487 7,350
Effect of exchange rate changes on cash and cash equivalents 138 (551) (825)
Cash and cash equivalents from subsidiaries sold, net (11) (15)
Cash and cash equivalents at end of the year $ 4,736 $ 11,721 $ 13,487